• TP53 Mutation, FTH, and Ferroptosis in Glioblastoma

  2026-09-30

  The reference study identifies an iron-homeostasis mechanism linking TP53 gain-of-function signaling to reduced ferritin heavy chain (FTH), increased labile iron, and ferroptosis sensitivity in glioblastoma models. Its findings support a genotype-informed strategy in which iron loading and ferroptosis induction are studied together, while also highlighting the need to validate the mechanism in clinically representative tumor systems.

• DNMT3B and Neuroendocrine Prostate Cancer Plasticity

  2026-09-30

  The reference study identifies DNMT3B as a driver of therapy-associated neuroendocrine lineage plasticity and stemness in prostate cancer. Genetic depletion and pharmacologic inhibition with Nanaomycin A reduced neuroendocrine prostate cancer growth in preclinical models, supporting DNMT3B as a candidate target for treatment-resistant disease.

• H-151 Links STING Inhibition to Ferroptosis Control

  2026-09-29

  The reference study shows that H-151, traditionally used as a covalent STING inhibitor, also suppresses ferroptosis through STING-independent radical-trapping antioxidant activity. By combining inflammatory pathway inhibition with protection against lipid peroxidation, H-151 reduced renal ischemia-reperfusion injury in mice and provides a mechanistic rationale for dual-pathway intervention.

• TP53, FTH, and Ferroptosis in Glioblastoma

  2026-09-29

  This study identifies a TP53 mutation–associated iron imbalance in glioblastoma in which increased ITCH expression promotes FTH degradation and raises intracellular free iron. The resulting state creates a potential ferroptosis vulnerability, particularly when iron loading is combined with Erastin, while also highlighting important limits of translating astrocyte and database findings into patient treatment strategies.

• Minoxidil sulphate: A Renal Vascular Assay Lens

  2026-09-28

  Minoxidil sulphate can serve as a mechanistic probe for potassium-channel and vasodilation research. This article translates renal sepsis findings into practical assay decisions while separating evidence-based interpretation from unvalidated extrapolation.

• Caspase-3 Fluorometric Assay Kit in RCC Research

  2026-09-28

  Track DEVD-dependent caspase activity in resveratrol-treated renal cancer cells with a fast fluorescence readout. This guide connects the 786-O cell study to practical controls, assay setup, and troubleshooting—while clarifying what the signal can and cannot establish about apoptosis.

• DNMT3B Drives Neuroendocrine Prostate Cancer Plasticity

  2026-09-27

  The study identifies DNMT3B as a driver of neuroendocrine and stemness-associated programs in treatment-resistant prostate cancer, and reports that genetic or pharmacologic inhibition suppresses NEPC features and tumor growth in experimental models. Its findings position DNMT3B as a candidate target for further study, while leaving important questions about mechanism, treatment parameters, and clinical relevance unresolved.

• H-151 Blocks Ferroptosis Beyond STING Inhibition

  2026-09-26

  The study reports that H-151, a covalent STING inhibitor, also acts as a radical-trapping antioxidant and suppresses ferroptosis independently of STING. In a murine renal ischemia-reperfusion injury model, its combined effects on inflammatory signaling and ferroptotic damage were associated with improved tissue injury and renal function, suggesting a dual-pathway strategy for further study.

• Staurosporine in Assay Design for Lens Aging Research

  2026-09-25

  Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor whose effects require careful interpretation in cell-based research. This article connects kinase perturbation assay design with new findings on GCLC truncation and age-related cataract—while clarifying what the evidence does and does not establish.

• H-151 Links STING Inhibition to Ferroptosis Control

  2026-09-25

  Yin and colleagues report that H-151, a covalent STING inhibitor, also suppresses ferroptosis by trapping radicals independently of STING. In a murine renal ischemia-reperfusion injury model, the compound’s combined effects on inflammatory signaling and lipid peroxidation were associated with less tissue damage and improved renal function, suggesting a dual-pathway strategy that merits further testing.

• Autophagy Buffers Resveratrol-Induced Apoptosis in RCC

  2026-09-24

  In renal carcinoma 786-O cells, resveratrol damaged mitochondria and triggered ROS-associated, caspase-3-dependent apoptosis, while ROS–JNK signaling also induced autophagy. Pharmacological or genetic inhibition of autophagy increased apoptosis, identifying a potential survival response that may be relevant to combination strategies but requires validation beyond this single-cell-line model.

• Vincristine Sulfate: Practical Cancer Research Workflows

  2026-09-24

  Build reproducible vincristine experiments around its microtubule-disrupting action, with guidance for stock preparation, dose-response design, and orthogonal readouts. This workflow separates product-specific evidence from practical starting conditions and clearly distinguishes vincristine research from unrelated findings on inflammation.

• TP53 Mutations, FTH, and Ferroptosis in Glioblastoma

  2026-09-23

  A 2025 study links TP53-mutant gain of function to increased ITCH expression, degradation of the iron-storage protein FTH, and altered iron handling in glioblastoma models. The findings suggest that reduced ferritin storage can make cells more vulnerable to Erastin-induced ferroptosis, particularly when iron availability is increased, while leaving important questions about model and treatment transferability.

• miRNA–mRNA Control of Juvenile Hormone Biosynthesis

  2026-09-23

  The reference study identifies coordinated miRNA–mRNA modules that regulate juvenile hormone biosynthetic genes in locust corpora allata during vitellogenesis. Its combination of transcriptomics, target validation, and agomiR perturbation links small-RNA regulation with juvenile hormone-dependent vitellogenin expression and ovarian development.

• Cyclic di-GMP Controls Biofilm Persistence via HipH

  2026-09-22

  Liao et al. identify cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during biofilm development. Their findings connect adhesion-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, expanding the mechanistic framework for biofilm resilience.

733 records 1/49 page Next 12345 下5页 Last page